Mitogen induced cellular cytotoxicity (MICC) in multiple myeloma.

Area of Science:

• Immunology
• Hematology

Background:

• Mitogen induced cellular cytotoxicity (MICC) is a measure of immune cell activity.
• Previous studies have not fully characterized MICC in multiple myeloma (MM) and chronic lymphocytic leukemia (CLL).

Purpose of the Study:

• To investigate and compare MICC levels in patients with multiple myeloma, CLL, and healthy controls.
• To identify the cell type responsible for mediating MICC in these populations.

Main Methods:

• Peripheral blood mononuclear cells were isolated from MM patients, CLL patients, and normal controls.
• MICC assays were performed using chicken red blood cells as target cells at varying effector-to-target cell ratios and mitogen concentrations.
• Adherent phagocytic cells were removed using carbonyl iron, glass wool, or rayon columns to identify the effector cell type.

Main Results:

• Patients with multiple myeloma exhibited significantly increased MICC compared to normal controls and CLL patients.
• Enhanced MICC was observed across different effector-to-target cell ratios and mitogen concentrations.
• Depletion of adherent, phagocytic cells completely abolished the MICC response in both MM patients and controls, indicating a monocytic effector cell.

Conclusions:

• The effector cell responsible for MICC in multiple myeloma and normal controls is likely monocytic.
• This monocytic effector cell may be similar to the suppressor cell for immunoglobulin synthesis found in multiple myeloma.
• The MICC assay using chicken red blood cells may serve as a valuable tool for identifying pathological conditions involving this specific cytotoxic cell population.